Optimistic Outlook for IN8bio: A Buy Rating Ahead of Key Data Release
TipRanksMay 1 00:15
Promising Preclinical Data Underpins Buy Rating for IN8bio's NsCAR Platform
TipRanksApr 12 13:45
IN8bio Analyst Ratings
BenzingaApr 10 22:49
HC Wainwright & Co. : The IN8bio (INAB.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $14.00.
Zhitong FinanceApr 10 22:50
Analysts Offer Insights on Healthcare Companies: TRACON Pharmaceuticals (TCON) and IN8bio (INAB)
TipRanksApr 10 22:20
Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN), Intuitive Surgical (ISRG) and IN8bio (INAB)
TipRanksMar 19 14:21
IN8bio Analyst Ratings
BenzingaMar 18 19:31
Analysts Offer Insights on Healthcare Companies: Vir Biotechnology (VIR) and IN8bio (INAB)
TipRanksMar 15 18:20
IN8bio Analyst Ratings
BenzingaMar 15 18:08
HC Wainwright & Co. Reiterates Buy on IN8bio, Maintains $14 Price Target
BenzingaMar 15 18:09
IN8bio Analyst Ratings
BenzingaMar 13 16:46
Analysts Offer Insights on Healthcare Companies: Vaxcyte (PCVX), Xeris Pharmaceuticals (XERS) and IN8bio (INAB)
TipRanksJan 9 14:50
HC Wainwright & Co. Reiterates Buy on IN8bio, Maintains $14 Price Target
BenzingaNov 13, 2023 23:52
IN8bio Analyst Ratings
BenzingaNov 13, 2023 23:49
Buy Rating Assigned to IN8bio: Promising Clinical Data and Favorable Q3 Financial Performance Propel Future Prospects
TipRanksNov 13, 2023 19:36
Analysts Offer Insights on Healthcare Companies: IN8bio (INAB) and Editas Medicine (EDIT)
TipRanksNov 8, 2023 14:50
Analyst Maintains Buy Rating for IN8bio Based on Positive SITC Release and Promising R&D Developments
TipRanksSep 29, 2023 14:39
HC Wainwright & Co. Reiterates Buy on IN8bio, Maintains $14 Price Target
BenzingaAug 11, 2023 19:25
IN8bio Analyst Ratings
BenzingaAug 11, 2023 19:16
IN8bio (INAB) Gets a Buy From H.C. Wainwright
TipRanksAug 11, 2023 18:45
No Data
No Data